Oxford BioMedica PLC (OTCPK:OXBDF)
$ 4.1 -0.21 (-4.87%) Market Cap: 415.78 Mil Enterprise Value: 425.58 Mil PE Ratio: 0 PB Ratio: 4.08 GF Score: 73/100

Half Year 2021 Oxford BioMedica PLC Earnings Call Transcript

Sep 22, 2021 / 12:00PM GMT
Release Date Price: $22.64 (+17.82%)
Sophia Bolhassan;Director of IR

Good afternoon, ladies and gentlemen. Welcome to Oxford Biomedica's Half Year Results Analyst Meeting and Conference Call for the 6 Months Ending 30 June 2021.

We're delighted to see many of you in person today to talk through what hopefully you will agree is a strong set of results. (Operator Instructions) And the presentation is being recorded. (Operator Instructions)

To discuss in more detail, I would like to introduce the presenters on the call today. We have our CEO, John Dawson; our CFO, Stuart Paynter; and our Chief Scientific Officer, Kyri Mitrophanous.

With that, I would like to hand over to John.

John Dawson
Oxford Biomedica plc - CEO & Executive Director

Thank you very much. And I'll first say, it's great to see you all face to face. It's been a while since we've been able to do this. It has a lot more impact when we do it sitting with you. Of course, the guys on the phone, it's great to have them there as well. It's a pleasure to have you all here to talk about our results

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot